Nirvana Life Sciences (XCNQ:NIRV) Change In Receivables : C$-0.01 Mil (TTM As of Jan. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Nirvana Life Sciences Change In Receivables?

Nirvana Life Sciences's change in receivables for the quarter that ended in Jan. 2024 was C$0.01 Mil. It means Nirvana Life Sciences's Accounts Receivable declined by C$0.01 Mil from Oct. 2023 to Jan. 2024 .

Nirvana Life Sciences's change in receivables for the fiscal year that ended in Apr. 2023 was C$-0.00 Mil. It means Nirvana Life Sciences's Accounts Receivable increased by C$0.00 Mil from Apr. 2022 to Apr. 2023 .

Nirvana Life Sciences's Accounts Receivable for the quarter that ended in Jan. 2024 was C$0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Nirvana Life Sciences's liquidation value for the three months ended in Jan. 2024 was C$-1.03 Mil.

Nirvana Life Sciences Change In Receivables Historical Data

The historical data trend for Nirvana Life Sciences's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nirvana Life Sciences Change In Receivables Chart

Nirvana Life Sciences Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Apr22

Apr23

Change In Receivables

Get a 7-Day Free Trial

0.01

-0.01

0.01

Nirvana Life Sciences Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Change In Receivables	Get a 7-Day Free Trial															-	-	-0.01	-	0.01

Nirvana Life Sciences Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.01 Mil.

Nirvana Life Sciences (XCNQ:NIRV) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Nirvana Life Sciences's Days Sales Outstanding for the quarter that ended in Jan. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Nirvana Life Sciences's accounts receivable are only considered to be worth 75% of book value:

Nirvana Life Sciences's liquidation value for the quarter that ended in Jan. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.003	-	1.029	+	0.75 * 0	+	0.5 * 0
=	-1.03

Nirvana Life Sciences Change In Receivables Related Terms

Thank you for viewing the detailed overview of Nirvana Life Sciences's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Nirvana Life Sciences (XCNQ:NIRV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nirvana Life Sciences Inc (XCNQ:NIRV) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8

Website

https://www.nirvanalifescience.com

Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.

Nirvana Life Sciences (XCNQ:NIRV) Headlines

No Headlines